{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T18:23:49Z","timestamp":1767032629786,"version":"3.48.0"},"reference-count":17,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":36,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pulm. circ."],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Pulmonary hypertension (PH) is a common complication in interstitial lung disease (ILD), but the additional burden it imposes on patients and healthcare systems is not well characterized. This retrospective analysis of claims data from the US Merative MarketScan database assessed hospitalization rates and costs over 2 years in patients with connective tissue disease\u2010related ILD (CTD\u2010ILD) and non\u2010CTD\u2010ILD with or without PH (between January 2017 and December 2019). Index was the date of first ILD claim; baseline was the 12\u2010month preindex period. In total, 16,129 patients with non\u2010CTD\u2010ILD (1502 [9%] with PH) and 4545 patients with CTD\u2010ILD (663 [15%] with PH) were identified. A higher proportion of patients with non\u2010CTD\u2010ILD with PH, compared with patients without PH, had all\u2010cause and heart failure (HF)\u2010related hospitalizations during baseline (all\u2010cause, 37.0% vs. 22.3%; HF\u2010related, 14.2% vs. 3.1%), 0\u201312 months (62.4% vs. 43.0%; 29.0% vs. 7.0%), and 13\u201324 months (44.7% vs. 18.3%; 21.5% vs. 3.2%) follow\u2010up (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001 for all). A significantly higher proportion of patients with CTD\u2010ILD with PH, compared with patients without PH, had all\u2010cause and HF\u2010related hospitalizations during baseline (all\u2010cause: 30.0% vs. 20.6%; HF\u2010related: 9.1% vs. 1.9%), 0\u201312 months (41.9% vs. 29.1%; 15.5% vs. 3.9%), and 13\u201324 months (37.9% vs. 18.9%; 13.9% vs. 2.5%) follow\u2010up (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001 for all). In both cohorts, total all\u2010cause and HF\u2010related costs were significantly higher in patients with PH at baseline, 0\u201312 months, and 13\u201324 months follow\u2010up (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05 for all). PH substantially increased hospitalization risks and costs in both types of ILD, underscoring the importance of improving outcomes in patients with ILD\u2010PH.\n                  <\/jats:p>","DOI":"10.1002\/pul2.70201","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:09:56Z","timestamp":1762434596000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incremental Burden of Pulmonary Hypertension Among Patients With Interstitial Lung Disease in the Real\u2010World Setting"],"prefix":"10.1002","volume":"15","author":[{"given":"Charles D.","family":"Burger","sequence":"first","affiliation":[{"name":"Mayo Clinic Jacksonville Florida USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmanda","family":"Wu","sequence":"additional","affiliation":[{"name":"Insmed Incorporated Bridgewater New Jersey USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"O'Brien","sequence":"additional","affiliation":[{"name":"Insmed Incorporated Bridgewater New Jersey USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalya","family":"Makulova","sequence":"additional","affiliation":[{"name":"Insmed Incorporated Bridgewater New Jersey USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Ward","sequence":"additional","affiliation":[{"name":"Panalgo Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghana G.","family":"Shamsunder","sequence":"additional","affiliation":[{"name":"Panalgo Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonny","family":"Shah","sequence":"additional","affiliation":[{"name":"Insmed Incorporated Bridgewater New Jersey USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeenat","family":"Safdar","sequence":"additional","affiliation":[{"name":"Houston Methodist Lung Center Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009-040GL"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01537-2014"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01914-2018"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008470"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01200-2024"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.09.002"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13665-022-00290-w"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0193"},{"key":"e_1_2_11_12_1","unstructured":"L. Hansen IBM MarketScan Research Databases for Life Sciences Researchers(IBM Watson Health 2018)."},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-03141-3"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.4046\/trd.2021.0141"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2023.05.002"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00165-X"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30250-4"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-9-201305070-00003"}],"container-title":["Pulmonary Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pul2.70201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T18:18:35Z","timestamp":1767032315000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pul2.70201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1002\/pul2.70201"],"URL":"https:\/\/doi.org\/10.1002\/pul2.70201","archive":["Portico"],"relation":{},"ISSN":["2045-8940","2045-8940"],"issn-type":[{"type":"print","value":"2045-8940"},{"type":"electronic","value":"2045-8940"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2025-04-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70201"}}